1
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------------------
FORM 10-K
[X] ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
FOR THE FISCAL YEAR ENDED DECEMBER 31, 2000
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
FOR THE TRANSITION PERIOD FROM TO
COMMISSION FILE NUMBER 1-13400
STRATASYS, INC.
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
DELAWARE 36-3658792
(STATE OR OTHER JURISDICTION OF (I.R.S. EMPLOYER
INCORPORATION OR ORGANIZATION) IDENTIFICATION NO.)
14950 MARTIN DRIVE, EDEN PRAIRIE, MINNESOTA 55344
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE)
(952) 937-3000
(REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE)
SECURITIES REGISTERED UNDER SECTION 12(b) OF THE ACT:
NAME OF EACH EXCHANGE ON WHICH
TITLE OF EACH CLASS EACH CLASS IS REGISTERED
------------------- ------------------------------
COMMON STOCK, $.01 PAR VALUE THE PACIFIC EXCHANGE INC.
SECURITIES REGISTERED UNDER SECTION 12(g) OF THE ACT: NONE
Indicate by check mark whether the Registrant: (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Exchange Act during the
preceding 12 months (or for such shorter period that the Registrant was required
to file such reports), and (2) has been subject to such filing requirements for
past 90 days.
Yes [X] No [ ]
Indicate by check mark if disclosure of delinquent filers pursuant to Item
405 of Regulation S-K is not contained herein, and will not be contained, to the
best of Registrant's knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this Form 10-K or any amendment to this
Form 10-K. [ ]
The aggregate market value of the Registrant's Common Stock held by
non-affiliates of the Registrant as of March 22, 2001 was approximately
$13,782,056.31. On such date, the closing price of the Registrant's Common
Stock, as quoted on the Nasdaq National Market, was $2.97.
DOCUMENTS INCORPORATED BY REFERENCE
Part III of the Annual Report on Form 10-K is herein incorporated by
reference from the Registrant's Definitive Proxy Statement to be filed with the
Securities and Exchange Commission with respect to the Registrant's Meeting of
Stockholders scheduled to be held on May 8, 2001.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
2
ITEM 1. DESCRIPTION OF BUSINESS.
GENERAL DEVELOPMENT OF BUSINESS
Stratasys manufactures and sells a line of rapid prototyping ("RP") devices
that create physical models from computerized designs. We were incorporated in
Delaware in 1989 and our executive offices are located in Eden Prairie,
Minnesota. Our rapid prototyping systems are based on our core patented fused
deposition modeling ("FDM(R)") technology or on recently developed and patented
Genisys(R) technology. We sold our first product, the 3-D Modeler, commercially
in April 1992 and introduced our second product, the Benchtop, in June 1993.
Other significant developments in our business are set forth below:
- On October 20, 1994, we successfully completed an initial public offering
of 1,380,000 shares of our common stock.
- In 1996 and 1997, we introduced several enhanced versions of our FDM
system. In 1997, we also introduced our Genisys system, which we
developed from technology that we acquired from IBM in 1995.
- In January 1998, we introduced the FDM Quantum(R), which offers large
modeling capabilities (the largest commercial build envelope in the
industry) combined with significant speed and performance enhancements as
compared with the FDM 2000. The FDM Quantum incorporates MagnaDrive
technology that allows the extrusion heads to move on a bed of air while
controlled by electro-magnetic homing devices.
- In December 1998, we acquired RP technology that we subsequently used to
develop our now commercial Prodigy(TM) system.
- In April 1999, we introduced the GenisysXs. This system offered enhanced
performance and speed improvements over the original Genisys.
- In August 1999, we introduced the FDM 3000 system based on our core FDM
technology. The FDM 3000 features a build envelope 60% larger than our
Benchtop systems. In conjunction with the FDM 3000, we introduced
WaterWorks(TM). The patented WaterWorks process allows for the easy
removal of supports from a completed prototype model by simple immersion
into a water-based solution.
- In July 2000, we introduced Prodigy(TM). Prodigy is a low-cost rapid
prototyping system that produces ABS parts for functional testing of
prototype designs. Prodigy offers office modeling, speed, ease of use,
and networking capabilities at a competitive price.
- We introduced the Maxum(TM) in November 2000. Maxum offers significant
speed enhancements over our previously released Quantum system. Maxum
features WaterWorks and Insight(TM), our new preprocessing software that
increases build speed and improves the design engineer's control and
efficiency over the entire build process. Insight was separately
introduced in February 2001 as a replacement for our QuickSlice software.
DESCRIPTION OF BUSINESS
We are a leader in the three dimensional ("3-D") imaging business, which is
referred to as "rapid prototyping". We develop, manufacture and market a family
of rapid prototyping devices that enable engineers and designers to create
physical models, tooling and prototypes out of plastic and other materials
directly from a computer aided design ("CAD") workstation. In many industries,
the models and prototypes required in product development are produced
laboriously by hand-sculpting or machining, a traditional process that can take
days or weeks. Our computerized modeling systems use our proprietary technology
to make models and prototypes more directly from a designer's three-dimensional
CAD in a matter of hours.
We believe that the RP systems using our FDM technology and Genisys
technology are the only rapid prototyping systems commercially available that
can produce parts from plastic without relying on lasers. This
1
3
affords our products a number of significant advantages over other commercially
available three-dimensional rapid prototyping technologies, which rely primarily
on lasers to create models. Such benefits include:
- the ability to use the device in an office environment due to the absence
of hazardous emissions
- the need for relatively little set up of the system for a particular
project
- the availability of a variety of modeling materials
- the lack of any need for costly replacement lasers and laser parts
Our systems can also run virtually unattended, producing models while designers
perform other tasks.
The process involved in the development of a three-dimensional model using
our FDM systems begins with the creation of a conceptual geometric model on a
CAD workstation. The model is then imported into our proprietary software
programs, which mathematically slice the conceptual model into horizontal layers
that are downloaded into the system. These rapid prototyping machines basically
draw cross-sections of the model one layer at a time to create a
three-dimensional "blueprint." A spool of thin thermoplastic modeling material
feeds into a moving FDM extruding head, which heats the material to a
semi-liquid state. This semi-liquid material is then extruded and deposited in
ultra-thin flat layers on a base (the "X-Y Stage") in the modeling chamber. As
the material is directed into place by the computer-controlled head, layer upon
layer, the material solidifies, creating a precise and strong laminated model.
The Genisys modeling process is similar. Genisys uses our proprietary
AutoGen(R) software to slice the conceptual model created on a CAD workstation
into horizontal layers that are downloaded into Genisys. Genisys then uses
wafers of polyester modeling material, rather than spools of filament, to feed
the extrusion head. The extrusion head heats these wafers and, using a precision
hydraulic pump, deposits a continuous layer of plastic polymer roads onto the
X-Y Stage to create a three-dimensional model by building up layers. In
comparison to the FDM systems, due to its size, Genisys allows the prototype to
be created on a desktop, directly from a workstation, like a 3-D printer. The
Company's recently-introduced GenisysXs uses a modeling process similar to the
original Genisys system.
PRODUCTS
Modeling Equipment. We have been developing and improving our line of
rapid prototyping products since our inception in 1989. Since we began selling
the 3-D Modeler, our first product, commercially in 1992, we have enhanced and
expanded our product line. We have improved both the speed and accuracy of our
FDM systems, we have expanded their build envelope, and we have developed and
introduced a low-cost 3-D printer based on technology that we acquired from IBM.
We have also enhanced and upgraded the software that our systems use to read CAD
files and build prototypes. Although we have discontinued the manufacture of the
3-D Modeler and the other systems that we introduced between 1992 and 1997, we
continue to support and maintain systems that are still in the field and to make
and sell the modeling materials that they use. Our current product line ranges
from our GenisysXs, a low-cost 3-D printer used for concept designs, to our
Maxum, that can be used to build functional prototypes and replacement parts.
GenisysXs offers enhanced performance and speed improvements over the
original Genisys. It is useful for the production of conceptual models employed
in the early stages of the design cycle, as it enables a designer to produce
concept iterations at his desk directly from a workstation in a simple
push-button fashion. We introduced GenisysXs in April 1999 and began shipping it
in May 1999.
Prodigy is our low-cost rapid prototyping system that produces ABS parts
for functional testing of prototype designs. Prodigy operates in the office,
offering speed, ease of use, and networking capabilities at a competitive price.
It is based on technology we purchased in December 1998 and further developed
throughout 1999 and the first half of 2000. We introduced it and began
commercial shipments in July 2000.
The FDM 2000 is an enhanced version of our FDM Benchtop system, but
features a 30% to 40% throughput improvement over its predecessor the FDM 1650.
Upgraded hardware and software accounts for the improved performance features.
We introduced and began shipment of the FDM 2000 in March 1997
2
4
The FDM 3000 system is based on our core patented FDM technology. It
features a build envelope 60% larger than our other Benchtop systems. In
conjunction with the FDM 3000, we introduced WaterWorks. The patented WaterWorks
process allows for the easy removal of supports from a completed prototype model
by simple immersion into a water-based solution. The support material is
dissolved, resulting in a cleaned prototype that eliminates most post-processing
requirements. We offered WaterWorks to users of our FDM 2000 systems in the
fourth quarter of 1999. We introduced the FDM 3000 in August 1999 and began
shipments in the fourth quarter of that year.
The FDM Maxum offers significant speed enhancements over our previously
released Quantum system. It incorporates MagnaDrive technology, which allows the
extrusion head to float on a bed of air while being controlled through
electromagnetic devices. This offers significant speed and performance
enhancements as compared with our benchtop systems. Maxum also features
WaterWorks and Insight, our new preprocessing software that increases build
speed and improves the design engineers' control and efficiency over the entire
build process. Insight was separately introduced in February 2001 as a
replacement for our QuickSlice software, which has been standard on all FDM
systems since 1993. We introduced Maxum in November 2000, and commercial
shipments commenced in December 2000.
Our family of rapid prototyping systems offers product designers and
developers the ability to create prototypes throughout all stages of the
development cycle as well as a wide range of prices from which to choose. The
domestic list prices of our systems range from $36,900 for a refurbished Genisys
Xs and reach $310,000 for the FDM Maxum. By comparison, our original 3D Modeler
sold for between $150,000 and $180,000. We also offer special pricing for
trade-in systems and upgrades. Customers have the option to purchase an entire
RP system from us or to buy individual components.
We have also adapted our FDM Benchtop technology for medical use. Our
MedModeler(TM) creates anatomical parts from computed tomography ("CT") and
magnetic resonance imaging ("MRI") devices. The U.S. Food and Drug
Administration granted us a 510(k) pre-market clearance in 1997 to sell the
MedModeler as a medical device.
Modeling Material. FDM technology allows the use of a greater variety of
modeling materials and colors than other technologies. We continue to develop
filament modeling materials that meet the customer's needs for increased speed,
strength, accuracy, surface resolution and color. These materials are processed
into our patented filament form, which is then fed into the FDM systems. Our
spool-based system has proven to be a significant advantage for our products
over Ultra Violet ("UV") polymer systems, because our system allows the user to
quickly change material by simply mounting the spool and threading the desired
material into the FDM devices. Spools weigh from 1.0 pound to ten pounds, and
the creation of a model may require from 0.1 pound to more than one pound of
filament. The spool-based system also compares favorably with UV polymer system,
because the spool-based system allows the customer to use the system in an
office environment and to purchase a single spool, as compared to an entire vat
of UV polymer, thereby reducing the customer's up-front costs.
Currently, we have six modeling materials commercially available for use
with our FDM technology:
- an elastomer material for applications requiring strength, durability and
flexibility, as used in seals or tubing
- an investment casting wax
- the hard polymer material ABS (named for its three initial monomers,
acrylonitrile, butadiene and styrene), which is used commercially to make
products such as cell phones, computer cases and toys
- a medical grade ABS (MABS), used for medical applications
- a release material, which is used for support and removed from the final
model
- a water-soluble material, which is used for support during the build
process and which is later dissolved from the finished prototype
3
5
Each material has specific characteristics that make it appropriate for
various applications. The ability to use different materials allows the user to
match the material to the end use application of the prototype, whether it is a
pattern for tooling or a concept model.
Genisys Xs uses only one type of modeling material, a plastic polymer,
which is manufactured in the form of wafers. A total of 50 wafers are held in a
cassette, which allows the wafers to be fed into the machine and rapidly
extruded in layers. Additional cassettes are easily loaded into the system. Each
cassette contains a memory chip that instructs the system as to the parameters
and melt temperature of the material lot, which optimizes the automatic build
process of the Genisys system.
The modeling filament and wafers are consumable products that provide us
additional revenue.
OPERATING SOFTWARE
Prior to 2001, we offered two proprietary software products: QuickSlice and
AutoGen. QuickSlice processes three-dimensional computer models to generate
operating data for our FDM 1650, 2000, 3000, 8000, and Quantum products. AutoGen
performs the same function for Genisys and GenesysXs 3-D Printers. We have
retained copyrights and all other ownership rights for AutoGen and QuickSlice.
QuickSlice is an interactive software product giving users choices ranging
from semi-automatic operations to a feature-rich array of options and controls.
In 1994, we developed SupportWorks(R), which is used in conjunction with
QuickSlice to automatically generate support structures, thereby eliminating a
time-consuming manual step in the modeling process. In 1995, we integrated
SupportWorks into QuickSlice.
In January 2001, we introduced Insight as a replacement for QuickSlice
software, which had been standard on all FDM systems since 1993. Insight is our
new preprocessing software that increases build speed and the design engineer's
control and efficiency over the entire build process. Insight will be offered to
users as an upgrade under our maintenance program.
AutoGen is an easy-to-use software product, giving users semi-automatic
operation for our Genisys and GenisysXs 3-D Printers. AutoGen is able to choose
most options and settings for the user, saving significant operator labor time.
AutoGen is included in the Genisys sales price.
APPLICATIONS FOR RAPID PROTOTYPING
Rapid prototyping systems enable engineers and designers to produce models
of their engineering designs faster and cheaper than with conventional manual
methods. Most companies use rapid prototyping to accelerate new product
development and improve time to market. The prototypes themselves are used to
test a product's or assembly's form, function and fit to specific tolerances.
Companies also use 3-D models for tooling as patterns for a variety of soft
tooling procedures. Wax investment casting masters are used in numerous
industries, including automotive, custom medical implants, and golf club
manufacturing.
We have positioned our products to be used as devices that support CAD
systems in a variety of design and manufacturing industries. Current
applications include:
- automotive - medical products
- areospace - education
- consumer products - service bureaus
- investment - packaging
casting
- government - form molding
- electronics - medical analysis
4
6
Additional future applications include:
- architectural design
- rapid manufacturing of small-volume custom parts
- free-form graphic design
- secondary tooling and mold-making
Among potential medical applications, rapid prototyping is being used to
produce accurate models of internal organs, bones or skulls for pre-operative
evaluations or modeling of prostheses. In such uses, our MedModeler is serving
as a peripheral device for CT and MRI devices.
MARKETING, DISTRIBUTION AND CUSTOMERS
The strategic focus of our marketing efforts begins with identifying the
needs of product managers, conceptual designers, design and manufacturing
engineers and production specialists in manufacturing and design companies. We
then seek to understand a customer's needs and requirements. To satisfy those
needs, we offer a broad array of products, ranging from the low-cost,
easy-to-use GenisysXs Printer, to the large-scale, fast and precise FDM Magnum.
We have sold systems to the following representative customers.
REPRESENTATIVE CUSTOMERS
- General Motors Corporation - Snap-On Tools Corporation - Hewlett-Packard
- Ford Motor Company - Xerox - Brooks Air Force Base
- Daimler Chrysler - Biomet, Inc. - Toyota
- Lockheed Martin - St. Jude Medical - Lego
- Square D. Company - Motorola - Federal Bureau of Investigation
- Whirlpool Corporation - Eastman Kodak Company - NASA
- Callaway Golf - Marubeni - Honda
We have also sold systems to service bureaus, universities and distributors
in the United States and abroad. We sell complete rapid prototyping systems as
well as supplies and services.
We use a variety of tactical marketing methods to reach potential
customers:
- Web-based marketing - press releases
- trade magazine - advertisements
articles
- brochures - direct mailings
- telemarketing programs - trade show demonstrations
- videos - a Web site
(www.Stratasys.com)
In addition, we have developed domestic and international on-site
demonstration capabilities.
Domestically, we sell directly to our customers. In 1997, we organized our
domestic FDM sales force into three regions. Salespersons and management reside
in the regions they service. In addition, GenisysXs resellers have been assigned
to managers within this regional framework. We market internationally through a
network of distributors and sales representatives. During the years ended
December 31, 2000, 1999 and 1998, export sales amounted to approximately
$18,606,700, $19,753,300 and $14,018,400, respectively.
No customer accounted for more than 10% of sales in 2000, 1999 or 1998.
5
7
WARRANTY AND SERVICE
We provide a 90-day warranty on our systems sold domestically and a
one-year warranty on those sold internationally. In addition, we offer annual
service and maintenance contracts for our systems. The service contracts include
updates of our software systems. Annual service contracts for our FDM systems
are priced from $2,500 to $50,000, while annual service contracts for the
GenisysXs system are priced from $8,000 to $10,000.
MANUFACTURING
Our manufacturing process consists of the assembly of purchased components.
We obtain all parts used in the manufacturing process either from distributors
of standard electrical or mechanical parts or from custom fabricators of our
proprietary designs. We currently operate on a build-to-forecast basis.
We purchase the major component parts for our FDM and office modeling
equipment from various outside vendors, subcontractors and other sources and
assemble them at our Minnesota facility. Our production floor has been organized
using demand-flow techniques in order to maximize efficiency and quality.
Computer-based Material Requirements Planning ("MRP") is used in the ordering of
parts to be delivered on-time to meet forecasted needs. At the completion of
assembly, we perform complete power up and final quality tests to ensure the
quality of our products before shipment to customers.
We maintain an inventory of most of our necessary supplies, which
facilitates the assembly of products required for production. Our sole current
supplier of the X-Y Stage for the FDM 2000, FDM 3000 and FDM 8000 systems is
Asymtek; and our sole current supplier of the FDM head motors is MircoMo
Electronics, Inc. We also have sole suppliers for two key components of our FDM
Maxum system. We consider all of these suppliers to be reliable. Nevertheless,
we maintain an inventory of such components to support continued supply.
Furthermore, we believe that the supplier of the X-Y Stage could be replaced by
in-house design and production of the part within a three-month period, if
necessary; and we could employ FDM head motors from other suppliers by
modifications to the design of the FDM 2000, 3000 and 8000 systems. In-house
development to replace the vendors of the Maxum components would take four to
eighteen months to accomplish. In regard to other parts and materials, we use
multiple sources of supply and do not believe that we are dependent on any
single supplier. Although we believe that we maintain adequate inventories of
vendor-specific materials, the loss of a supplier of such vendor-specific
materials or compounds could result in a delay in the manufacture and delivery
of those materials and compounds resulting from the need to retest and recertify
products supplied by one or more new vendors. We consider our relationships with
our suppliers to be good.
RESEARCH AND DEVELOPMENT
We believe that ongoing research and development efforts are essential to
our continued success. Accordingly, our engineering development efforts will
continue to focus on improvements to the FDM technology and development of new
modeling processes, materials, software and products. We have devoted
significant time and resources to the development of a universally compatible
and user-friendly software system. To date, much of our activity has been
focused on research and development. For the years ended December 31, 2000, 1999
and 1998, our research and development expenses, excluding the non-recurring
charge for purchase of in-process engineering, were approximately $6,367,000,
$6,583,000 and $5,944,000, respectively.
Our filament development and production operation is located at our
facility in Eden Prairie, Minnesota. We regard the filament formulation and
manufacturing process as a trade secret, and we hold patent claims on filament
usage in our products.
INTELLECTUAL PROPERTY
We consider our proprietary technology to be material to the development,
manufacture, and sale of our products and seek to protect our technology through
a combination of patents and confidentiality agreements
6
8
with our employees and others. Scott Crump, Stratasys' President, was granted
two U.S. patents that cover many claims relating to various aspects of our
products, FDM technology and the associated modeling process. The term of one
patent lasts until June 9, 2009, and the term of the other lasts until August
23, 2011. The patents have been assigned to us. In addition, other employees
have assigned us patents and patent applications for other rapid prototyping
processes and apparatuses associated with the FDM process. As part of our
purchase of rapid prototyping technology assets from IBM, we were also assigned
the rights and title to three patents developed by IBM, which cover the Genisys
system and which we believe will further augment our own product lines. We
recorded these patents domestically and are in the process of recording them in
certain foreign countries. The terms of these patents extend until June 7, 2005,
April 12, 2011, and May 17, 2011. In total, we currently own 16 primary U.S.
patents. Corresponding patent applications covering the same claims that are
contained in our issued patents have been initiated in various foreign
countries. Other foreign patent applications have also been filed, including the
patent applications assigned to the Company by IBM.
Our registered trademarks include:
REGISTERED TRADEMARKS
- Stratasys, Inc. - AutoGen
- 3D Modeler - FDMM
- QuickSlice - FDC
- 3D Plotter - BMD
- 3D Visualizer - FDM Quantum
- FDM - Genisys
Other trademarks include:
- FDM Maxum - 3D Printer
- BASS - Prodigy
- Catalyst - WaterWorks
- Insight - SupportWorks
Each of the registered trademarks has a duration of 10 years and may be
renewed every 10 years while it is in use. Trademark applications have also been
filed in Japan and the European Community.
We have also registered the following Internet domain names:
- prototype.com - webmodeling.com
- webprototypes.com - 3D-fax.com
- 3DPrinter.com - Stratasys.com
WORKING CAPITAL PRACTICES
We do not engage in unusual practices regarding inventories, receivables or
other items of working capital.
BACKLOG
Our total backlog of system orders at December 31, 2000 was approximately
$7 million, as compared with $4.0 million at December 31, 1999. We estimate that
20% of our backlog will not be shipped in 2001. Since sales of our products are
typically strongest in the fourth quarter, orders during that period have a
significant bearing on our backlog for the subsequent fiscal year.
7
9
COMPETITION
We compete in a marketplace that is still dominated by conventional methods
of model-making and prototype development. Machinists and engineers working from
blueprints or CAD files and using machining or by-hand methods generally perform
the prototype development and fabrication. We believe that there is currently no
other commercial producer of 3-D modeling devices that uses a single-step,
non-toxic technology similar to our FDM and Genisys technologies. Most other
rapid prototyping or 3-D printing systems involve an additional post-processing
step, such as curing the part after construction of the model or prototype. Our
FDM and Genisys technologies do not rely on the laser or light technology used
by many other commercial manufacturers in the rapid prototyping industry.
Our competitors employ a number of different technologies in their rapid
prototyping devices. 3D Systems, D-MEC, Mitsui and Teijin Seiki Co. use
stereolithography in their products. 3D Systems introduced the first rapid
prototyping product. We believe that 3D Systems has accounted for approximately
27% of rapid prototyping units sold to date. DTM Corporation and EOS produce
machines that use lasers to sinter or harden powdered material. Z Corp. uses
inkjet technology to sinter powdered materials. Sanders Prototype, Inc. and 3D
Systems have developed prototyping systems that use inkjet technology to deposit
wax material layer by layer, which can be used in an office environment. A
smoothing or milling process is required between each deposited layer to
maintain accuracy in these processes. We believe that our FDM and Genisys
technologies have important advantages over our competitors' products. These
advantages include:
- the ability to be used in an office environment
- the availability of multiple strong modeling materials
- a one-step modeling process
- ease of use
- automated support removal
Certain of our competitors have greater financial and marketing resources
than we have. We believe that in 2000 we were the second largest in the industry
in terms of unit shipments and were the third largest RP company in revenue.
EMPLOYEES
As of March 16, 2001, we had 182 full-time employees and four
subcontractors or temporary employees. While we have separate internal
departments, such as manufacturing, marketing, engineering and sales, many
employees perform overlapping functions within the organization. No employee is
represented by a union, and we have not experienced a work stoppage. We believe
our employee relations are good.
GOVERNMENTAL REGULATION
General
We are subject to various local, state and federal laws, regulations and
agencies that affect businesses generally. These include:
- regulations promulgated by federal and state environmental and health
agencies
- the federal Occupational Safety and Health Administration
- laws pertaining to the hiring, treatment, safety and discharge of
employees
FDA Regulation
The FDA has the authority to regulate the preclinical and clinical testing,
manufacture, labeling, distribution, and promotion of our MedModeler FDM system
as a Class II medical device under the Federal Food, Drug, and Cosmetic Act of
1976. In November 1997, we announced that the FDA had granted the
8
10
MedModeler FDM system 510(k) clearance. We have subsequently made modifications
to the MedModeler, which we believe do not require the submission of a new
510(k) notification. There can be no assurance, however, that the FDA would
agree with our determination not to submit, or would not require us to submit, a
new 510(k) notification for any of these changes.
The MedModeler is subject to pervasive and continuing regulation by the
FDA. Our medical sector manufacturing facility will be subject to inspection by
the FDA to assure compliance with its Quality System Regulation ("QSR"), which
imposes testing, control, documentation and other quality assurance procedures.
In addition, we will be subject to other regulatory requirements that usually
apply to medical devices marketed in the United States, including:
- labeling regulations
- Medical Device Reporting ("MDR") regulations which require that a
manufacturer report to the FDA certain types of adverse events involving
its products
- the FDA's prohibitions against promoting products for unapproved or
"off-label" uses
In addition, Class II devices can be subject to additional special controls
that do not apply to Class I devices, such as performance standards, postmarket
surveillance, patient registries, and FDA guidelines.
The MedModeler FDM system may be subject in certain instances to regulation
by foreign regulatory authorities to the extent that we seek to market it
outside the United States.
FINANCIAL INFORMATION ABOUT OPERATIONS IN THE UNITED STATES AND OTHER COUNTRIES
The information required by this item is incorporated by reference to our
Financial Statements included elsewhere in this report. (See Part IV, Item 14,
Note 13.)
ITEM 2. PROPERTIES.
Our executive offices and production facilities presently occupy
approximately 87,156 square feet in two adjacent buildings in Eden Prairie,
Minnesota, near Minneapolis. We occupy a 27,756 square foot facility under a
lease that was to expire on July 31, 1999. In July 1998, we extended this lease
until July 31, 2002. In October 1996, we leased an additional 59,400 square feet
of office and production space in a building adjacent to our original Eden
Prairie premises under a lease expiring in December 1999. In June 1999, we
exercised our renewal option to lease this facility through November 2001.
Approximately 25% of the new premises is being sublet until we need it. The
Minnesota facilities are used for machine assembly and filament production, as
well as sales, administration and operations. The current monthly rent for the
premises that we occupy totals approximately $35,000. We do not require a large
space for production, because we assemble our devices from sub-assemblies
manufactured by outside vendors.
In February 2001, we entered into an agreement to purchase our current
manufacturing facility for approximately $2,990,000, This purchase is subject to
financing, environmental, and other due diligence contingencies. We expect to
close on this purchase in May 2001.
We opened two regional sales offices in 1997. In June 1997, we entered into
a lease, which was amended in May 1998, under which we occupy 2,889 square feet
of space in Southfield, Michigan, a suburb of Detroit. Our monthly rent is
$5,056 under that lease, which expires in April 2001. In September 1997, we
entered into a three-year lease or occupy 2,504 square feet of space in Ontario,
California. We renewed this lease in 2001 for a two-year period and monthly rent
of $3,190. We are also responsible for real estate taxes, insurance, utilities,
trash removal, and maintenance expenses at both of these facilities. In November
1997, our German subsidiary entered into a lease to occupy 4,360 square feet of
space in Frankfurt, Germany. The lease expires in November 2001, with base
monthly rent of approximately $6,100.
9
11
ITEM 3. LEGAL PROCEEDINGS.
We are not a party to any pending legal or administrative proceeding, and
our property is not subject to any such proceeding, other than actions arising
in the ordinary course of our business, which we believe are not material.
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF STOCKHOLDERS.
No matter was submitted to a vote of stockholders, through the solicitation
of proxies or otherwise, during the fourth quarter of the fiscal year ended
December 31, 2000.
PART II
ITEM 5. MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS.
MARKET INFORMATION
Our common stock is quoted on the National Association of Securities
Dealers, Inc. Automated Quotation System National Market ("Nasdaq") under the
symbol SSYS and is traded on The Pacific Stock Exchange Incorporated under the
symbol SAS.
The following table sets forth the high and low closing bid prices of the
Company's common stock for each quarter from January 1, 1999 through the fiscal
year ended December 31, 2000.
HIGH LOW
------ -----
BID PRICES $
---------------
Fiscal Year Ended December 31, 2000
January 1, 2000 -- March 31, 2000........................... 12.75 7.375
April 1, 2000 -- June 30, 2000.............................. 9.500 5.688
July 1, 2000 -- September 30, 2000.......................... 7.625 5.375
October 1, 2000 -- December 31, 2000........................ 6.000 2.063
Fiscal Year Ended December 31, 1999
January 1, 1999 -- March 31, 1999........................... 5.625 3.750
April 1, 1999 -- June 30, 1999.............................. 4.688 3.313
July 1, 1999 -- September 30, 1999.......................... 4.438 3.433
October 1, 1999 -- December 31, 1999........................ 9.25 3.313
There were approximately 140 stockholders of record of our common stock as
of March 20, 2001.
DIVIDENDS
We have not paid or declared any cash dividends to date and do not
anticipate paying any in the foreseeable future. We intend to retain earnings,
if any, to support the growth of our business.
10
12
ITEM 6. SELECTED CONSOLIDATED FINANCIAL DATA.
The selected consolidated financial data as of and for the five-year period
ended December 31, 2000, should be read in conjunction with the Consolidated
Financial Statements and related Notes for the year ended December 31, 2000, and
the Management's Discussion and Analysis of Financial Condition and Results of
Operations.
YEARS ENDED DECEMBER 31,
------------------------------------------
2000 1999 1998 1997 1996
------ ------ ------ ------ ------
(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)
STATEMENT OF OPERATIONS DATA:
Sales................................................. 35,611 37,587 32,437 29,636 22,920
Gross Profit.......................................... 21,948 24,675 21,347 19,940 15,031
Selling, general and administrative expenses.......... 15,138 15,611 15,320 14,676 9,486
Research and development.............................. 6,367 6,583 5,944 5,055 3,374
Purchased in-process research and development......... -- -- 6,513 -- --
Operating income (loss)............................... 444 2,481 (6,429) 209 2,172
Net income (loss)..................................... 988 2,144 (3,318) 515 3,503
Net income (loss) per basic share..................... 0.18 0.37 (0.55) 0.09 0.67
Weighted average basic shares outstanding............. 5,527 5,776 6,072 5,726 5,191
Net income (loss) per diluted share................... 0.17 0.37 (0.55) 0.09 0.63
Weighted average diluted shares outstanding........... 5,684 5,779 6,072 6,016 5,585
2000 1999 1998 1997 1996
------ ------ ------ ------ ------
(IN THOUSANDS)
BALANCE SHEET DATA
Working Capital....................................... 20,014 19,567 18,655 26,357 20,192
Total Assets.......................................... 37,582 37,113 41,190 38,984 31,463
Long term debt (less current portion)................. 130 318 193 136 95
Stockholders' equity.................................. 29,226 28,783 28,103 33,087 26,406
ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS.
GENERAL
We develop, manufacture, and market a family of rapid prototyping devices
that enable engineers and designers to create physical models, tooling and
prototypes out of plastic and other materials directly from a CAD workstation.
Historically, our growth has come from sales to a number of industries,
including automotive, consumer products, electronics, medical, and aerospace.
Universities, other educational institutions, and service bureaus have also been
significant markets for us. Our current and future growth is largely dependent
upon our ability to penetrate new markets, and develop and market new rapid
prototyping devices and applications that meet the needs of our current and
prospective customers. We are presently focusing new product developments on
various rapid prototyping devices, modeling materials, and software
enhancements. We anticipate that in 2001 our primary business strategy will
focus on expanding international and domestic sales of our existing family of
rapid prototyping devices, while maintaining on-going development of new rapid
prototyping equipment, modeling materials, and software.
In July 2000 we introduced Prodigy. Prodigy is a low cost rapid prototyping
system that produces ABS parts for functional testing of prototype designs.
Prodigy offers office modeling, speed, ease of use, and networking capabilities
at a competitive price. It is based on technology we purchased in December 1998
and further developed throughout 1999 and the first half of 2000. We began
commercial shipments of Prodigy in July 2000.
We introduced the Maxum in November 2000. Maxum offers significant speed
enhancements over our previously released systems. It features WaterWorks, a
soluble support feature that virtually eliminates post-
11
13
processing time by dissolving model supports. Maxum also features Insight, our
new preprocessing software that increases build speed and improves the design
engineers' control and efficiency over the entire build process. Insight was
separately introduced in February 2001 as a replacement for our QuickSlice
software, which had been standard on all of our FDM systems since 1993.
For the first time since 1990, net revenue derived from our rapid
prototyping devices, modeling materials, and maintenance did not increase over
the prior year. However, our 297 gross unit shipments in 2000 were the highest
in our history. Our gross profit declined to 61.6% of sales in 2000 from 65.6%
in 1999, despite shipping more units. Our gross profit can be significantly
impacted by shifts in our product mix and sales volume. In 2000 we continued our
high level of spending on research and development ("R&D") for both new products
and sustaining engineering. R&D expenditures amounted to $6,366,800 in 2000 as
compared with $6,583,120 in 1999, but as a percentage of sales increased to
17.9% in 2000 from 17.5% in 1999. Selling, General and Administrative ("SG&A")
expenses declined by 3.0% in 2000 over 1999, but as a percentage of sales
increased to 42.5% from 41.5% of revenue in 1999. As a result of declining sales
and profitability, we reduced our head count of employees and contractors by
approximately 8% in January 2001. This reduction in workforce should result in
reduced operating expenses of approximately $2 million in 2001. While we believe
that profitability will improve in 2001 as compared with 2000 as a result of
continued operating expense control, we can give no assurance that these results
will be realized.
We believe that the rapid prototyping industry is growing at approximately
5-10% per year, and that 3D printers and office modelers account for more than
30% of the total units of rapid prototyping systems shipped. We believe that
there is a long-term trend toward lower priced rapid prototyping systems capable
of producing functional prototypes, and that a sizable market exists for concept
or visualization 3D printers. This pricing trend should lead to growth in the
more traditional functional prototyping marketplace as companies continue to
address in-house rapid prototyping and concept-modeling needs. Certain market
segments in the industry have not demonstrated significant pricing sensitivity.
These segments are more interested in modeling envelope size, modeling material,
throughput, part quality, part durability, and rapid tooling, which should allow
growth to continue for higher priced rapid prototyping systems addressing these
needs.
RESULTS OF OPERATIONS
Year Ended December 31, 2000 Compared With Year Ended December 31, 1999
The following table sets forth certain statement of operations data as a
percentage of net sales for the periods indicated. All items are included in or
derived from our statement of operations.
FOR THE YEARS ENDED
DECEMBER 31,
--------------------
2000 1999
------- -------
Net sales.................................................. 100.0% 100.0%
Cost of sales.............................................. 38.4% 34.4%
Gross margin............................................... 61.6% 65.6%
Selling, general, and administrative expenses.............. 42.5% 41.5%
Research & development expense............................. 17.9% 17.5%
Operating income........................................... 1.2% 6.6%
Other income............................................... 1.4% 1.1%
Income before taxes........................................ 2.6% 7.7%
Income taxes (benefit)..................................... (.2)% 2.0%
Net income................................................. 2.8% 5.7%
Net Sales
Net sales for the year ended December 31, 2000 were $35,610,547, compared
with sales of $37,586,938 for the year ended December 31, 1999. This represents
a decrease of $1,976,391, or 5.3%. Sales of our Benchtop systems were
particularly strong in 2000, and constituted our strongest product line. Prodigy
system
12
14
sales also contributed significantly to our 2000 results following its July 2000
introduction. Consumable and maintenance revenues also increased in the twelve
months ended December 31, 2000 as compared with 1999. Maintenance and materials
revenues were enhanced by the larger installed base of systems, customer
satisfaction with ABS, WaterWorks, and other material selections, and continued
emphasis on the sale of maintenance contracts.
Our gross shipments amounted to 297 systems in 2000 compared with 293
systems in 1999. System sales in 2000 included gross shipments of all systems,
including trade-in and upgrade systems. The average selling price of our systems
declined in 2000 as compared with 1999, which was significantly influenced by
product mix shifts. Product mix can dramatically affect the average selling
price in any period. We ended 2000 with an order backlog in excess of $7,000,000
compared with an order backlog of approximately $3,900,000 at December 31, 1999.
The 2000 year-end backlog is the highest in our history.
Domestic sales accounted for approximately 57% of total revenue in 2001,
which is up from 52% recorded in 1999. In the United States, the central region
recorded the highest revenue. Europe accounted for approximately 19% of total
revenue in 2000, an improvement from 18% of revenue recorded in 1999. Our
combined Asia-Pacific region, which comprises Japan, China, the Far East and
India, accounted for approximately 23% of total revenue, down from the 29%
attained in 1999. We believe that year 2001 sales into our Asia Pacific and
European regions will remain strong. No assurances, however, can be given that
future sales and profitability will not be adversely impacted by the economic
conditions of these regions.
Gross Profit
Gross profit decreased to $21,948,464, or 61.6% of sales, in the year ended
December 31, 2000, compared with $24,675,038, or 65.6% of sales, in the year
ended December 31, 1999. This represents a deterioration of $2,726,574, or
11.0%. Gross profit decreased due to a shift in our product mix to lower-priced
systems, increased overhead expenses, and write-offs of approximately $600,000
of inventory for obsolescence and scrap.
Operating Expenses
SG&A expenses decreased to $15,138,072 for the year ended December 31,
2000, from $15,611,257 for the year ended December 31, 1999. This represents a
decrease of $473,185, or 3.0%. Reductions to commissions, amortization, and
warranty expenses accounted for much of the decrease in 2000 as compared with
1999.
R&D expenses declined to $6,366,800 for the year ended December 31, 2000
from $6,583,120 for the year ended December 31, 1999. The decrease in 2000 from
1999 amounted to $216,320, or 3.3%. Increases to personnel expenses were more
than offset by reductions to contract labor and materials in 2000. In early
January 2001, we announced a layoff in which approximately 8% of our headcount,
some of whom were contractors, were terminated. These cuts were concentrated in
the R&D and selling departments. Future expense savings should amount to
approximately $2,000,000. A provision for severance and outplacement expenses
was taken in the fourth quarter and is reflected in our operating expenses of
the period.
Our operating income for the year ended December 31, 2000 amounted to
$443,592, or 1.2% of sales, compared with operating income of $2,480,661, or
6.6% of sales, for the year ended December 31, 1999.
Other Income
Other income and expense netted to $482,296 in 2000 compared with $408,988
in 1999. Interest income amounted to $551,841 in 2000 compared with $452,855 in
1999. Interest expense increased $69,545 in 2000 from $43,867, representing the
financing effect of higher capitalized lease balances.
Net Income (Loss)
For the reasons cited above, net income for 2000 amounted to $988,301, or
2.8% of sales, compared with net income of $2,143,649, or 5.7% of sales in 1999.
This resulted in 2000 income per diluted common and
13
15
common equivalent share of $.17 compared with income per diluted common and
common equivalent share of $.37 for the period ended December 31, 1999.
Year Ended December 31, 1999 Compared With Year Ended December 31, 1998
The following table sets forth certain statement of operations data as a
percentage of net sales for the periods indicated. All items are included in or
derived from our statement of operations.
FOR THE YEARS ENDED
DECEMBER 31,
--------------------
1999 1998
------- -------
Net sales.................................................. 100.0% 100.0%
Cost of sales.............................................. 34.4% 34.2%
Gross margin............................................... 65.6% 65.8%
Selling, general, and administrative expenses.............. 41.5% 47.2%
Purchased in-process research and development.............. 0.0% 20.1%
Research & development expense............................. 17.5% 18.3%
Operating income (loss).................................... 6.6% (19.8)%
Other income............................................... 1.1% 2.3%
Income (loss) before taxes................................. 7.7% (17.6)%
Income taxes (benefit)..................................... 2.0% (7.3)%
Net income (loss).......................................... 5.7% (10.2)%
Net Sales
Net sales for the year ended December 31, 1999 were $37,586,938, compared
with sales of $32,437,198 for the year ended December 31, 1998. This represents
an increase of $5,149,740, or 15.9%. Sales of our Benchtop systems, augmented by
the introduction of the FDM 3000 system introduced in August 1999, were
particularly strong in 1999, and continued to account for the majority of our
system sales. Quantum and GenisysXs system sales were also up, following their
respective 1998 and 1999 introductions. Consumable and maintenance revenues also
increased in the twelve months ended December 31, 1999 as compared with the same
1998 period. Maintenance and materials revenues were enhanced by the larger
installed base of systems, customer satisfaction with ABS, WaterWorks, and other
consumable offerings, and increased emphasis on the sale of maintenance
contracts.
We shipped 293 systems in 1999 compared with shipments of 262 systems in
1998. System sales in 1999 included sales of all systems, including trade-in and
refurbished systems. We ended 1999 with an order backlog of approximately
$4,000,000 compared with an order backlog of approximately $3,500,000 at
December 31, 1998. The 1999 year-end backlog was the highest in our history.
Domestic sales accounted for approximately 52% of total revenue in 1999,
which was down from 58% recorded in 1998. Europe accounted for approximately 18%
of total revenue in 1999, down from 19% of 1998 revenue. Our Asia-Pacific
region, which comprises Japan, China, Southeast Asia and India, accounted for
approximately 29.5% of total revenue, up from the 22% attained in 1998.
Historically, we have derived a larger percentage of our revenues from Europe as
well as countries other than Japan in the Asia-Pacific region.
Gross Profit
Gross profit increased to $24,675,038, or 65.6% of sales, in the year ended
December 31, 1999, compared with $21,347,127, or 65.8% of sales, in the year
ended December 31, 1998, an improvement of $3,327,911, or 15.6%. Gross profit
increased due to higher sales volume and overhead expenses that increased at a
lesser rate than sales. Gross profit was negatively impacted by higher material
and direct labor cost of goods sold that resulted primarily from changes in our
product mix.
14
16
Operating Expenses
SG&A expenses increased to $15,611,257 for the year ended December 31,
1999, from $15,319,918 for the year ended December 31, 1998. This represents an
increase of $291,339, or 1.9%, which was well below the 15.9% revenue growth
that the Company recorded. Personnel expenses, primarily in our sales and
service organizations, variable commissions expense, and regional sales office
expenses accounted for much of the increase in 1999 as compared with 1998. As a
percentage of sales, SG&A expenses declined to 41.5% in 1999 from 47.2% in 1998.
R&D expenses, excluding the non-recurring charge for the purchase of
in-process research and development, increased to $6,583,120 for the year ended
December 31, 1999 from $5,943,926 for the year ended December 31, 1998. The
increase in 1999 over 1998 amounted to $639,194, or 10.8%. Personnel expenses,
professional services, and expenses associated with the development of the
purchased in-process engineering technology accounted for much of the increase
in R&D expenses in 1999 as compared with 1998. The 1998 non-recurring pre-tax
charge for the purchase of in-process research and development amounted to
$6,512,665, and was expensed because of the risk associated with the purchased
research and development as well as the significant amount of engineering
resources required of the Company to commercialize this technology. As a
percentage of sales, excluding the purchase of in-process research and
development, R&D expenses declined to 17.5% in 1999 from 18.3% in 1998.
Our operating income for the year ended December 31, 1999 amounted to
$2,480,661, or 6.6% of sales, compared with operating loss of $6,429,382, or
19.8% of sales, for the year ended December 31, 1998. Without the non-recurring
charge, the operating income would have been $83,283, or .3% of 1998 sales.
Other Income
Other income and expense netted to $408,988 in 1999 compared with $736,037
in 1998. Interest income amounted to $452,855 in 1999 compared with $789,638 in
1998. This was due to a lower average balance of cash and marketable securities
in 1999. Interest expense declined by $9,734 to $43,867 in 1999 as we paid down
various capitalized leases.
Net Income (Loss)
For the reasons cited above, net income for 1999 amounted to $2,143,649, or
5.7% of sales, compared with a net loss of $3,318,015, or (10.2%) of sales in
1998. This resulted in 1999 income per diluted common and common equivalent
share of $.37, compared with loss per common and common equivalent share of $.55
for the period ended December 31, 1998. Excluding the non-recurring charge for
the purchase of in-process research and development, our pro forma net income
for the period ended December 31, 1998 would have been approximately $533,000,
which represented pro forma income per diluted common and common equivalent
share of $.09.
LIQUIDITY AND CAPITAL RESOURCES
Operating activities during 2000 provided cash of $663,286, primarily
reflecting our net income of $988,301, an increase to unearned maintenance
revenues of $391,752, and a decrease to accounts receivable of $259,742.
Unearned maintenance revenues increased as a result of renewed selling emphasis
and larger installed base of customers. Increases to inventories and prepaid
expenses used cash of $2,455,553 and $246,352, respectively. Inventories
increased due to higher levels of replacement parts required under maintenance
agreements, the expanded number of products, and the revenue shortfall in our
fourth quarter. Operating activities during 1999 provided cash of $2,694,397,
primarily reflecting our 1999 net income of $2,143,649, and in increase to
unearned maintenance contracts of $1,276,759. Increases to our accounts
receivable and inventory balances used cash of $1,917,421 and $1,611,677,
respectively. Our investing activities provided cash of $4,445,221 in 2000,
primarily reflecting net proceeds of $6,000,620 from the sale of marketable
securities. However, we used cash to acquire property and equipment and for
payments of intangible assets of $978,359 and $577,040, respectively. In 1999,
we used $9,769,231 of cash in our investing activities, including $6,464,709
used for the purchase of in-process research and development, and $1,330,761
15
17
for payments for intangible assets. In 2000 financing activities used $878,915
of cash, including $731,135 for the repurchase of outstanding common stock and
$230,229 for payments of obligations under capital leases. In 1999, our
financing activities used net cash of $1,646,781, which included $1,465,315 for
the repurchase of outstanding common stock under its stock buyback program and
$183,752 for payments of obligations under capital leases. The net increase in
cash, for the reasons cited above, amounted to $4,204,947 in 2000 compared with
a net decrease in cash of $8,711,480 for the year ended December 31, 1999. Our
ending cash and cash equivalents balances as of December 31, 2000 and 1999 were
$6,737,306 and $2,532,359, respectively.
At December 31, 2000, our cash, cash equivalents, and marketable securities
balances totaled $6,737,306. This cash will be used for working capital
purposes, for the purchase and improvement of our manufacturing facility, for
new product development, for acquisition of production equipment and tooling,
for computers, for increased selling and marketing activities, and for
engineering costs required to develop and commercialize the in-process research
and development acquisition. Additionally, we may continue our common stock
buyback program. We purchased 109,400 shares of our common stock for an
aggregate cost of $731,135 in 2000. While we believe that the primary source of
liquidity in 2000 will be derived from current cash balances and cash flows from
operations, we have opened a line of credit for the lesser of $4,000,000 or a
defined borrowing base. To date, we have not borrowed against this credit
facility.
As of December 31, 2000, we had gross accounts receivable of $11,954,874,
less an allowance of $458,359 for returns and doubtful accounts. Historically,
our bad debt expense has been minimal. However, at December 31, 2000, large
balances were concentrated with certain international distributors. Default by
one or more of these distributors would result in a significant charge against
our current reported earnings. While we can give no assurances, we believe that
most, if not all, of the accounts receivable balances will ultimately be
collected.
Our total current assets amounted to $28,238,869 at December 31, 2000, the
majority of which consisted of cash, cash equivalents, inventories and accounts
receivable. Total current liabilities amounted to $8,225,336. Our debt is
minimal, consisting primarily of principal payments due under capital leases of
$318,012. We estimate that we will spend approximately $1,200,000 in 2001 for
facility improvements, production and R&D equipment, computers and integrated
software, and tooling. In addition, we have entered into an agreement to
purchase our existing manufacturing facility for approximately $2,990,000. We
expect to use approximately $750,000 of our cash to pay a part of the purchase
price and to finance the balance through a mortgage on the property. However,
since we expect our mortgage payments to be less than our current rent, we
believe that the purchase will have a positive effect on our future cash flow.
As of December 31, 2000, material commitments for inventory purchases from
selected vendors for the ensuing twelve-month period ending December 31, 2002
should amount to approximately $2,500,000. We intend to finance these purchases
from existing funds or from cash flows from operations.
INFLATION
We believe that inflation has not had a material effect on our operations
or on our financial condition during the three most recent fiscal years.
FOREIGN CURRENCY TRANSACTIONS
Throughout most of 2000, substantially all of our recognized revenues were
invoiced in United States dollars. Therefore, our exposure to foreign currency
exchange rates was immaterial. Commencing in October 2000, we began invoicing
revenues in foreign currencies, primarily in euros. Therefore, our operating
results could be subject to fluctuations based upon changes in the exchange
rates of these currencies in relation to the United States dollar. To date, we
have not used financial hedging techniques to minimize the effects of these
fluctuations. However, we will continue to monitor our exposure to currency
fluctuations, and, when appropriate, may use financial hedging techniques in the
future. Instruments to hedge our risks may include foreign currency forward,
swap, and option contracts. These instruments will be used to selectively manage
risk but there can be no assurances that we will be fully protected against
material foreign currency fluctuations. Translation exposure to our balance
sheet with respect to foreign operations is not hedged. Most
16
18
of our revenue is still expected to be derived from areas where the transactions
are negotiated, invoiced, and paid in US dollars. Fluctuations in the currency
exchange rates in these other countries may therefore reduce the demand for our
products by increasing the price of our products in the currency of countries in
which the local currency has declined in value.
FORWARD-LOOKING STATEMENTS AND FACTORS THAT MAY AFFECT FUTURE RESULTS OF
OPERATIONS
All statements herein that are not historical facts or that include such
words as expect, anticipate, project, estimates or believes or other similar
words are forward-looking statements deemed by us to be covered by and to
qualify for the safe harbor protection covered by the safe harbor protection
provided by the Private Securities Litigation Reform Act of 1995 (the "1995
Act"). Investors and prospective investors in our Company should understand that
several factors govern whether any forward-looking statement herein will be or
can be achieved. Any one of these factors could cause actual results to differ
materially from those projected herein. These forward-looking statements include
the expected increases in net sales of rapid prototyping systems and services,
our ability to maintain our gross margins on these sales, and our plans and
objectives to introduce new products, control expenses, and improve
profitability. The forward-looking statements included herein are based on
current expectations that involve a number of risks and uncertainties. These
forward-looking statements are based on assumptions, among others, that we (1)
will be able to continue to introduce new rapid prototyping systems acceptable
to the market and improve existing technology and software in its current
product offering (2) will be able to maintain our gross margins on our present
products, (3) will be able to control our operating expenses, and (4) will be
able to retain and recruit employees with the necessary skills to produce,
develop, market, and sell our products. Assumptions relating to the foregoing
involve judgments with respect to, among other things, future economic,
competitive, market and technology conditions and future business decisions, all
of which are difficult or impossible to predict accurately and many of which are
beyond our control. Although we believe that the assumptions underlying the
forward-looking statements contained herein are reasonable, any of those
assumptions could prove inaccurate, and therefore there is and can be no
assurance that the results contemplated in any such forward-looking statement
will be realized. The impact of actual experience and business developments may
cause us to alter our marketing plans, our capital expenditure budgets, or our
engineering, selling or other budgets, which may in turn affect our results of
operations or the success of its new product development and introduction. Due
to the factors noted above and elsewhere in the Management's Discussion and
Analysis of Financial Condition and Results of Operations, our future earnings
and stock price may be subject to significant volatility, particularly on a
quarterly basis. Additionally, we may not learn of revenue or earnings
shortfalls until late in a fiscal quarter, since we frequently receive the
majority of our orders very late in a quarter. This could result in an immediate
and adverse effect on the trading price of our common stock. Past financial
performance should not be considered a reliable indicator of future performance,
and investors should not use historical trends to anticipate results or trends
in future periods.
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.
The information that appears following Item 14 of this report and is
incorporated herein by reference.
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
FINANCIAL DISCLOSURE.
The Company did not have any changes in or disagreements with its
accountants on accounting and financial disclosure.
17
19
PART III
ITEM 10. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT.
Incorporated herein by reference to the Company's Definitive Proxy
Statement with respect to the Company's Annual Meeting of Stockholders scheduled
to be held May 8, 2001.
ITEM 11. EXECUTIVE COMPENSATION.
Incorporated herein by reference to the Company's Definitive Proxy
Statement with respect to the Company's Annual Meeting of Stockholders scheduled
to be held May 8, 2001.
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT.
Incorporated herein by reference to the Company's Definitive Proxy
Statement with respect to the Company's Annual Meeting of Stockholders scheduled
to be held May 8, 2001.
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS.
Incorporated herein by reference to the Company's Definitive Proxy
Statement with respect to the Company's Annual Meeting of Stockholders scheduled
to be held May 8, 2001.
ITEM 14. EXHIBITS, FINANCIAL STATEMENT SCHEDULES AND REPORTS ON FORM 8-K.
(a) DOCUMENTS
1. Financial Statements --
Independent Auditors Report................................. F-1
Consolidated Balance Sheets December 31, 1999 and 1998...... F-2
Consolidated Statements of Operations Years ended December
31, 1999, 1998 and 1997................................... F-3
Consolidated Statements of Stockholders' Equity Years ended
December 31, 1999, 1998 and 1997.......................... F-4
Consolidated Statements of Cash Flows Years ended December
31, 1999, 1998 and 1997................................... F-5
Notes to Consolidated Financial Statements.................. F-15
2. Financial Statement Schedule --
Schedule II -- Valuation and Qualifying Accounts............ F-6-F-14
Notes
All other schedules called for under Regulation S-X are not submitted
because they are not applicable or not required, or because the required
information is included in the financial statements or notes thereto.
Separate financial statements of the Registrant have been omitted because
the Registrant is primarily an operating company. All subsidiaries included in
the consolidated financial statements are majority owned, and none of the
subsidiaries have indebtedness which is not guaranteed by the Registrant.
18
20
3. Exhibits
EXHIBIT
NO. DESCRIPTION
------- -----------
3.1 Restated Certificate of incorporation of the Company.(3)
3.2 Amendment to Certificate of Incorporation of the Company.(6)
3.3 By-Laws of the Company.(1)
4.1 Agent's Warrant issued to R.J. Steichen & Company dated
November 12, 1993.(1)
4.2 Agent's Warrant issued to R.J. Steichen & Company dated
December 13, 1993.(1)
4.3 Form of Common Stock purchase warrants issued by the Company
dated as of November 12, 1993 and December 13, 1993.(1)
4.4 Form of Common Stock purchase warrant issued by the Company
in its August 1995 private placement.(2)
4.5 Form of 3-year Common Stock purchase warrants issued by the
Company in its November 1995 offering under Regulation D and
Regulation S.(5)
4.6 Form of 3-month Common Stock purchase warrants issued by the
Company in its November 1995 offering under Regulation D and
Regulation S.(5)
4.7 Form of Placement Agent's warrant issued by the Company in
its November 1995 offering under Regulation D and Regulation
S.(5)
4.8 Form of warrant issued to Sunrise Securities Corp. by the
Company in connection with its November 1995 offering under
Regulation D and Regulation S.(5)
10.1 Non-Competition Agreement between the Company and S. Scott
Crump, dated October 15, 1990.(1)
10.2 Non-Competition Agreement between the Company and S. Lisa
Crump, dated October 15, 1990.(1)
10.3 Employee Confidentiality Agreement between the Company and
S. Scott Crump, dated October 15, 1990.(1)
10.4 Employee Confidentiality Agreement between the Company and
Lisa Crump, dated October 15, 1990.(1)
10.5 Stratasys, Inc. Employee Stock Option Plan #1.(1)
10.6 Amended and Restated Stratasys, Inc. 1994 Stock Plan.(3)
10.7 Second Amended and Restated Stratasys, Inc. 1994-2 Stock
Plan.(8)
10.8 Stratasys, Inc. 1998 Incentive Stock Option Plan.(10)
10.9 Asset Purchase Agreement between the Company and IBM dated
January 1, 1995.(4)
10.10 Stratasys, Inc. 2000 Incentive Stock Option Plan.(13)
10.11 Equipment Lease Agreement between the Company and IBM dated
January 1, 1995.(4)
10.12 Assignment, dated October 23, 1989, from S. Scott Crump to
the Company with respect to a patent application for an
apparatus and method for creating three-dimensional
objects.(7)
10.13 Assignment, dated June 5, 1992, from S. Scott Crump to the
Company with respect to a patent application for a modeling
apparatus for three dimensional objects.(7)
10.14 Assignment, dated June 1, 1994, from S. Scott Crump, James
W. Comb, William R. Priedeman, Jr., and Robert Zinniel to
the Company with respect to a patent application for a
process and apparatus of support removal for
three-dimensional modeling.(7)
10.15 Lease between the Company and Welsh Edenvale Partners '86,
dated October 9, 1992.(1)
10.16 Amendment #4 to Lease between the Company and Welsh Edenvale
Partners '86, dated October 9, 1992, between the Company and
Carpenter Land Company LLP, dated July 27, 1998.(14)
19
21
EXHIBIT
NO. DESCRIPTION
------- -----------
10.17 Lease between the Company and Richard A. Burke, dated
October 14, 1996.(9)
10.18 Warrant Purchase Agreement by and among the Company and
certain holder's of the Company's Warrants dated September
30, 1998.(11)
10.19 Technology Sale and Assignment Agreement, between the
Company and SEK Technologies LLC, dated as of December 21,
1998.(12)
10.21 User Agreement, between the Company and SEK Technologies
LLC, dated as of August 21, 1997.(12)
10.22 Option Agreement, between the Company and SEK Technologies
LLC, dated August 21, 1997.(12)
10.23 Form of Registration Rights Agreement, between the Company
and holders of Investment Units in SEK Technologies LLC,
dated as of January 4, 1999.(12)
21.1 Subsidiaries of the Company.(14)
23.1 Consent of Rothstein, Kass & Company, P.C.
---------------
(1) Incorporated by reference from the Company's Registration Statement on Form
SB-2 (File No. 33-83638-C) filed September 2, 1994.
(2) Incorporated by reference from the Company's Form 8-K, dated August 24,
1995.
(3) Incorporated by reference from the Company's Form 10-KSB for the year ended
December 31, 1994.
(4) Incorporated by reference from the Company's Form 8-K, Amendment No. 2,
dated January 1, 1995.
(5) Incorporated by reference from the Company's Registration Statement on Form
SB-2 (File No. 33-99108) filed November 8, 1995.
(6) Incorporated by reference from the Company's Form 10-QSB for the nine
months ended September 30, 1995.
(7) Incorporated by reference from Amendment No. 1 to the Company's
Registration Statement on Form SB-2 (File No. 33-99108) filed December 20,
1995.
(8) Incorporated by reference from the Company's definitive Proxy Statement on
Schedule 14A with respect to the Company's 1997 Annual Meeting of
Stockholders.
(9) Incorporated by reference from the Company's Form 10-KSB for the year ended
December 31, 1996.
(10) Incorporated by reference from the Company's definitive Proxy Statement on
Schedule 14A with respect to the Company's 1998 Annual Meeting of
Stockholders.
(11) Incorporated by reference from the Company's Form 8-K filed on October 16,
1998.
(12) Incorporated by reference from the Company's Form 8-K filed January 15,
1999.
(13) Incorporated by reference from the Company's Registration Statement on Form
S-8 (File No. 333-32782) filed March 17, 2000.
(14) Incorporated by reference from the Company's Form 10-K for the year ended
December 31, 1999.
(b) REPORTS ON FORM 8-K
None.
20
22
STRATASYS, INC. AND SUBSIDIARIES
CONSOLIDATED FINANCIAL STATEMENTS
AND
INDEPENDENT AUDITORS' REPORT
DECEMBER 31, 2000 AND 1999
22
23
STRATASYS, INC. AND SUBSIDIARIES
CONTENTS
INDEPENDENT AUDITORS' REPORT................................ F-1
CONSOLIDATED FINANCIAL STATEMENTS
Balance Sheets............................................ F-2
Statements of Operations.................................. F-3
Statements of Stockholders' Equity........................ F-4
Statements of Cash Flows.................................. F-5
Notes to Financial Statements............................. F-6-F-14
Schedule II -- Valuation and Qualifying Accounts and
Reserves............................................... F-15
23
24
INDEPENDENT AUDITORS' REPORT
Board of Directors
Stratasys, Inc.
We have audited the accompanying consolidated balance sheets of Stratasys,
Inc. and Subsidiaries (the "Company") as of December 31, 2000 and 1999, and the
related consolidated statements of operations, stockholders' equity, and cash
flows and financial statement schedule for each of the three years in the period
ended December 31, 2000. These financial statements are the responsibility of
the Company's management. Our responsibility is to express an opinion on these
financial statements based on our audits.
We conducted our audits in accordance with auditing standards generally
accepted in the United States of America. Those standards require that we plan
and perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in the financial
statements. An audit also includes assessing the accounting principles used and
significant estimates made by management, as well as evaluating the overall
financial statement presentation. We believe that our audits provide a
reasonable basis for our opinion.
In our opinion, the consolidated financial statements referred to above
present fairly, in all material respects, the consolidated financial position of
Stratasys, Inc. and Subsidiaries as of December 31, 2000 and 1999, and the
results of their operations and their cash flows for each of the three years in
the period ended December 31, 2000, in conformity with accounting principles
generally accepted in the United States of America. Also in our opinion, the
financial statement schedule referred to above, when considered in relation to
the basic consolidated financial statements taken as a whole, presents fairly,
in all material respects, the information required to be included therein.
/s/ Rothstein, Kass & Company, P.C.
ROTHSTEIN, KASS & COMPANY, P.C.
Roseland, New Jersey
February 2, 2001
F-1
24
25
STRATASYS, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
DECEMBER 31, 2000 1999
------------ ----------- -----------
ASSETS
CURRENT ASSETS
Cash and cash equivalents................................. $ 6,737,306 $ 2,532,359
Marketable securities..................................... 6,000,620
Accounts receivable, less allowance for returns and
doubtful accounts of $458,359 in 2000 and $420,833 in
1999................................................... 11,496,515 11,756,257
Inventories............................................... 9,102,818 6,647,265
Prepaid expenses.......................................... 673,230 429,211
Deferred income taxes..................................... 229,000 214,000
----------- -----------
Total current assets.............................. 28,238,869 27,579,712
----------- -----------
PROPERTY AND EQUIPMENT, net................................. 2,905,620 3,235,362
----------- -----------
OTHER ASSETS
Intangible assets, net.................................... 3,521,561 3,409,708
Deferred income taxes..................................... 2,687,000 2,507,000
Other..................................................... 228,681 381,534
----------- -----------
6,437,242 6,298,242
----------- -----------
$37,581,731 $37,113,316
=========== ===========
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES
Obligations under capital leases, current portion......... $ 187,692 $ 230,229
Accounts payable and other current liabilities............ 3,719,309 3,855,447
Unearned maintenance revenues............................. 4,318,335 3,926,583
----------- -----------
Total current liabilities......................... 8,225,336 8,012,259
----------- -----------
OBLIGATIONS UNDER CAPITAL LEASES, less current portion...... 130,320 318,012
----------- -----------
COMMITMENTS
STOCKHOLDERS' EQUITY
Common stock, $.01 par value, authorized 15,000,000
shares; issued 6,125,994 shares in 2000 and 6,101,961
shares in 1999......................................... 61,260 61,020
Capital in excess of par value............................ 32,907,547 32,712,755
Accumulated deficit....................................... (715,579) (1,703,880)
Accumulated other comprehensive loss...................... (48,776) (39,608)
Less cost of treasury stock, 652,000 shares in 2000 and
542,600 shares in 1999................................. (2,978,377) (2,247,242)
----------- -----------
Total stockholders' equity........................ 29,226,075 28,783,045
----------- -----------
$37,581,731 $37,113,316
=========== ===========
See accompanying notes to consolidated financial statements.
F-2
25
26
STRATASYS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
YEARS ENDED DECEMBER 31, 2000 1999 1998
------------------------ ----------- ----------- -----------
SALES............................................... $35,610,547 $37,586,938 $32,437,198
COST OF SALES....................................... 13,662,083 12,911,900 11,090,071
----------- ----------- -----------
GROSS PROFIT........................................ 21,948,464 24,675,038 21,347,127
----------- ----------- -----------
COSTS AND EXPENSES
Research and development.......................... 6,366,800 6,583,120 5,943,926
Purchased in-process research and development..... 6,512,665
Selling, general and administrative............... 15,138,072 15,611,257 15,319,918
----------- ----------- -----------
21,504,872 22,194,377 27,776,509
----------- ----------- -----------
OPERATING INCOME (LOSS)............................. 443,592 2,480,661 (6,429,382)
----------- ----------- -----------
OTHER INCOME (EXPENSE)
Interest and other income......................... 551,841 452,855 789,638
Interest expense.................................. (69,545) (43,867) (53,601)
----------- ----------- -----------
482,296 408,988 736,037
----------- ----------- -----------
INCOME (LOSS) BEFORE INCOME TAXES (BENEFIT)......... 925,888 2,889,649 (5,693,345)
INCOME TAXES (BENEFIT).............................. (62,413) 746,000 (2,375,330)
----------- ----------- -----------
NET INCOME (LOSS)................................... $ 988,301 $ 2,143,649 $(3,318,015)
=========== =========== ===========
INCOME (LOSS) PER COMMON AND COMMON EQUIVALENT SHARE
Basic............................................. $ 0.18 $ 0.37 $ (0.55)
=========== =========== ===========
Diluted........................................... $ 0.17 $ 0.37 $ (0.55)
=========== =========== ===========
WEIGHTED AVERAGE NUMBER OF COMMON AND COMMON
EQUIVALENT SHARES OUTSTANDING
Basic............................................. 5,527,144 5,775,945 6,071,787
=========== =========== ===========
Diluted........................................... 5,684,318 5,779,340 6,071,787
=========== =========== ===========
See accompanying notes to consolidated financial statements.
F-3
26
27
STRATASYS, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
ACCUMULATED
COMMON STOCK CAPITAL IN OTHER
YEARS ENDED DECEMBER 31, 2000, ------------------- EXCESS OF ACCUMULATED COMPREHENSIVE TREASURY
1999, AND 1998 SHARES AMOUNT PAR VALUE DEFICIT LOSS STOCK TOTAL
------------------------------ --------- ------- ----------- ----------- ------------- ----------- -----------
BALANCES, JANUARY 1, 1998.... 6,079,659 $60,797 $33,556,084 $ (529,514) $ -- $ -- $33,087,367
EXERCISE OF STOCK OPTIONS.... 20,865 208 68,640 68,848
REPURCHASE OF WARRANTS....... (1,000,000) (1,000,000)
WARRANTS ISSUED IN CONNECTION
WITH PURCHASED RESEARCH AND
DEVELOPMENT................ 85,760 85,760
NET LOSS..................... (3,318,015) (3,318,015)
OTHER COMPREHENSIVE LOSS.....
Cumulative translation
adjustment................. (38,956) (38,956)
Total comprehensive loss.....
PURCHASE OF 137,300 SHARES OF
TREASURY STOCK............. (781,927) (781,927)
--------- ------- ----------- ----------- -------- ----------- -----------
BALANCES, DECEMBER 31, 1998... 6,100,524 61,005 32,710,484 (3,847,529) (38,956) (781,927) 28,103,077
EXERCISE OF STOCK OPTIONS.... 1,437 15 2,271 2,286
NET INCOME................... 2,143,649 2,143,649
OTHER COMPREHENSIVE LOSS.....
Cumulative translation
adjustment................. (652) (652)
Total comprehensive income...
PURCHASE OF 405,300 SHARES OF
TREASURY STOCK............. (1,465,315) (1,465,315)
--------- ------- ----------- ----------- -------- ----------- -----------
BALANCES, DECEMBER 31, 1999... 6,101,961 61,020 32,712,755 (1,703,880) (39,608) (2,247,242) 28,783,045
EXERCISE OF STOCK OPTIONS AND
WARRANTS................... 24,033 240 82,209 82,449
WARRANTS ISSUED FOR
SERVICES................... 112,583 112,583
NET INCOME................... 988,301 988,301
OTHER COMPREHENSIVE LOSS.....
Cumulative translation
adjustment................. (9,168) (9,168)
Total comprehensive income...
PURCHASE OF 109,400 SHARES OF
TREASURY STOCK............. (731,135) (731,135)
--------- ------- ----------- ----------- -------- ----------- -----------
BALANCES, DECEMBER 31, 2000... 6,125,994 $61,260 $32,907,547 $ (715,579) $(48,776) $(2,978,377) $29,226,075
========= ======= =========== =========== ======== =========== ===========
COMPREHENSIVE
YEARS ENDED DECEMBER 31, 2000, INCOME
1999, AND 1998 (LOSS)
------------------------------ -------------
BALANCES, JANUARY 1, 1998....
EXERCISE OF STOCK OPTIONS....
REPURCHASE OF WARRANTS.......
WARRANTS ISSUED IN CONNECTION
WITH PURCHASED RESEARCH AND
DEVELOPMENT................
NET LOSS..................... $(3,318,015)
OTHER COMPREHENSIVE LOSS.....
Cumulative translation
adjustment................. (38,956)
-----------
Total comprehensive loss..... $(3,356,971)
===========
PURCHASE OF 137,300 SHARES OF
TREASURY STOCK.............
BALANCES, DECEMBER 31, 1998...
EXERCISE OF STOCK OPTIONS....
NET INCOME................... $ 2,143,649
OTHER COMPREHENSIVE LOSS.....
Cumulative translation
adjustment................. (652)
-----------
Total comprehensive income... $ 2,142,997
===========
PURCHASE OF 405,300 SHARES OF
TREASURY STOCK.............
BALANCES, DECEMBER 31, 1999...
EXERCISE OF STOCK OPTIONS AND
WARRANTS...................
WARRANTS ISSUED FOR
SERVICES...................
NET INCOME................... $ 988,301
OTHER COMPREHENSIVE LOSS.....
Cumulative translation
adjustment................. (9,168)
-----------
Total comprehensive income... $ 979,133
===========
PURCHASE OF 109,400 SHARES OF
TREASURY STOCK.............
BALANCES, DECEMBER 31, 2000...
See accompanying notes to consolidated financial statements.
F-4
27
28
STRATASYS, INC. AND SUBSIDIARIES
CONSOLIATED STATEMENTS OF CASH FLOWS
YEARS ENDED DECEMBER 31, 2000 1999 1998
------------------------ ----------- ----------- -----------
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)................................... $ 988,301 $ 2,143,649 $(3,318,015)
Adjustments to reconcile net income (loss) to net
cash provided by operating activities:
Deferred income taxes............................ (195,000) 594,000 (2,388,000)
Depreciation..................................... 1,302,893 1,265,396 1,341,045
Amortization..................................... 465,187 638,643 929,249
Warrants issued for services..................... 112,583
Purchased in-process research and development.... 6,512,665
Loss on disposal of property and equipment....... 4,686 77,474
Increase (decrease) in cash attributable to
changes in assets and liabilities
Accounts receivable............................ 259,742 (1,917,421) 1,827,218
Inventories.................................... (2,455,553) (1,611,677) 456,542
Prepaid expenses............................... (246,352) 166,859 (367,273)
Other assets................................... 154,613 (206,894)
Accounts payable and other current
liabilities................................. (119,566) 267,609 519,624
Unearned maintenance revenues.................. 391,752 1,276,759 223,554
----------- ----------- -----------
NET CASH PROVIDED BY OPERATING ACTIVITIES............. 663,286 2,694,397 5,736,609
----------- ----------- -----------
CASH FLOWS FROM INVESTING ACTIVITIES
Proceeds from sale of marketable securities......... 13,500,000 23,500,000 40,090,164
Acquisition of marketable securities................ (7,499,380) (24,927,971) (40,241,253)
Acquisition of property and equipment............... (978,359) (628,290) (1,190,567)
Proceeds from sale of property and equipment........ 82,500
Purchased in-process research and development....... (6,464,709)
Payments for intangible assets...................... (577,040) (1,330,761) (341,980)
Payments for other assets, net...................... (7,900)
----------- ----------- -----------
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES... 4,445,221 (9,769,231) (1,691,536)
----------- ----------- -----------
CASH FLOWS FROM FINANCING ACTIVITIES
Payments of obligations under capital leases........ (230,229) (183,752) (178,024)
Repurchase of warrants.............................. (1,000,000)
Exercise of stock options and warrants.............. 82,449 2,286 68,848
Purchase of treasury stock.......................... (731,135) (1,465,315) (781,927)
----------- ----------- -----------
NET CASH USED IN FINANCING ACTIVITIES................. (878,915) (1,646,781) (1,891,103)
EFFECT OF EXCHANGE RATE CHANGES ON CASH............... (24,645) 10,135 (26,363)
----------- ----------- -----------
NET INCREASE (DECREASE) IN CASH AND CASH
EQUIVALENTS......................................... 4,204,947 (8,711,480) 2,127,607
CASH AND CASH EQUIVALENTS, beginning of year.......... 2,532,359 11,243,839 9,116,232
----------- ----------- -----------
CASH AND CASH EQUIVALENTS, end of year................ $ 6,737,306 $ 2,532,359 $11,243,839
=========== =========== ===========
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION,
cash paid during the year for:
Interest............................................ $ 69,545 $ 43,867 $ 53,601
=========== =========== ===========
Income taxes........................................ $ 253,265 $ -- $ 437,916
=========== =========== ===========
SUPPLEMENTAL SCHEDULES OF NONCASH INVESTING AND
FINANCING ACTIVITIES, machinery and equipment
acquired under capital lease obligations............ $ -- $ 369,997 $ 268,569
=========== =========== ===========
See accompanying notes to consolidated financial statements.
F-5
28
29
STRATASYS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
1. NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Nature of Operations
Stratasys, Inc. and Subsidiaries (collectively the "Company") develops,
manufactures and markets a family of rapid prototyping systems ("RPS") and
devices that permit engineers and designers to create physical models and
prototypes, made of various materials, utilizing three dimensional Computer
Aided Design ("3D CAD") files at a CAD workstation. The Company sells these
devices and the related consumable materials and maintenance worldwide.
Principles of Consolidation
The consolidated financial statements include the accounts of Stratasys,
Inc. and its wholly owned subsidiaries. All material intercompany accounts and
transactions have been eliminated in consolidation.
Fair Value of Financial Instruments
The fair value of the Company's assets and liabilities, which qualify as
financial instruments under Statement of Financial Accounting Standards (SFAS)
No. 107, "Disclosures About Fair Value of Financial Instruments", approximate
the carrying amounts presented in the consolidated balance sheets.
Cash Equivalents
The Company considers all highly-liquid debt instruments purchased with an
original maturity of three months or less to be cash equivalents. Cash
equivalents include U.S. Treasury bills and a money market account.
Marketable Securities
The Company records its marketable securities in accordance with SFAS No.
115, "Accounting for Certain Investments in Debt and Equity Securities."
Marketable securities have been categorized as held to maturity and, as a
result, are stated at amortized cost at December 31, 1999. The Company's
marketable securities consist of U.S. Treasury bills that mature within one
year.
Inventories
Inventories are stated on the first-in, first-out method, at the lower of
cost, or market. Inventory costs are comprised of material, direct labor and
overhead.
Impairment of Long-Lived Assets
The Company periodically assesses the recoverability of the carrying
amounts of long-lived assets, including intangible assets. A loss is recognized
when expected undiscounted future cash flows are less than the carrying amount
of the asset. The impairment loss is the difference by which the carrying amount
of the asset exceeds its fair value.
Property and Equipment
Property and equipment is stated at cost less accumulated depreciation and
amortization. Depreciation and amortization is computed using the straight-line
method over the estimated useful lives of the assets ranging from 3-5 years.
F-6
29
30
STRATASYS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
Intangible Assets
Intangible assets are being amortized over their estimated useful or
economic lives using the straight-line method as follows:
RPS Technology............................................. 11 years
Capitalized software development costs..................... 3 years
Purchased software......................................... 3 years
Patents.................................................... 10 years
The costs of software development, including significant product
enhancements, incurred subsequent to establishing technological feasibility have
been capitalized in accordance with SFAS No. 86, "Accounting for the Costs of
Computer Software to be Sold, Leased or Otherwise Marketed." Costs incurred
prior to establishment of technological feasibility are charged to research and
development expense.
Unearned Maintenance Revenues
Maintenance revenues are amortized over the term of the related maintenance
contracts, which are typically one to two years.
Revenue Recognition
The Company recognizes revenues from the sale of RPS machines when shipped.
The Company establishes allowances for estimated returns at the time of
shipment. Service revenues, excluding maintenance contracts, are recognized at
the time the services are performed.
Advertising
Advertising costs are charged to operations as incurred and were
approximately $704,000, $652,000 and $603,000 for 2000, 1999 and 1998,
respectively.
Research and Development Costs
Expenditures for research, development and engineering of products and
manufacturing processes are expensed as incurred.
Income Taxes
The Company complies with SFAS No. 109, "Accounting for Income Taxes,"
which requires an asset and liability approach to financial reporting of income
taxes. Deferred income tax assets and liabilities are computed for differences
between the financial statement and tax bases of assets and liabilities that
will result in taxable or deductible amounts in the future, based on enacted tax
laws and rates applicable to the periods in which the differences are expected
to affect taxable income. Valuation allowances are established, when necessary,
to reduce the deferred income tax assets to the amount expected to be realized.
Income (Loss) Per Common Share
The Company complies with SFAS No. 128, "Earnings Per Share". SFAS No. 128
requires dual presentation of basic and diluted income (loss) per share for all
periods presented. Basic income (loss) per share excludes dilution and is
computed by dividing income available to common stockholders by the weighted
average number of common shares outstanding for the period. Diluted income per
share reflects the potential dilution that could occur if securities or other
contracts to issue common stock were exercised or converted into common stock or
resulted in the issuance of common stock that then shares in the income of
30 F-7
31
\ STRATASYS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
the Company. The difference between the number of shares used to compute basic
income (loss) per share and diluted income (loss) per share relates to
additional shares to be issued upon the assumed exercise of stock options and
warrants, net of shares hypothetically repurchased at the average market price
with the proceeds of exercise of 157,174 in 2000, 3,395 in 1999, and nil in
1998.
Stock-Based Compensation
The Company follows SFAS No. 123 "Accounting for Stock-Based Compensation."
The provisions of SFAS No. 123 allow companies to either expense the estimated
fair value of stock options or to continue to follow the intrinsic value method
set forth in APB Opinion 25, "Accounting for Stock Issued to Employees" ("APB
25") but disclose the pro forma effect on net income (loss) had the fair value
of the options been expensed. The Company has elected to continue to apply ABP
25 in accounting for its stock option incentive plans.
Use of Estimates
The preparation of financial statements in conformity with accounting
principles generally accepted in the United States of America requires
management to make estimates and assumptions that affect the reported amounts of
assets and liabilities and disclosure of contingent assets and liabilities at
the date of the financial statements and the reported amounts of revenues and
expenses during the reporting period. Actual results could differ from those
estimates.
Comprehensive Income (Loss)
The Company complies with SFAS No. 130, "Reporting Comprehensive Income".
SFAS No. 130 establishes rules for the reporting and display of comprehensive
income (loss) and its components; however, the compliance with this Statement
has no impact on the Company's net income (loss) or stockholders' equity. SFAS
No. 130 requires the Company's change in the foreign currently translation
adjustment to be included in other comprehensive income (loss).
2. ACCOUNTS RECEIVABLE
At December 31, 2000 and 1999, accounts receivable included balances due
from foreign entities of approximately $6,714,000 and $7,205,000, respectively.
3. INVENTORIES
Inventories consist of the following at December 31:
2000 1999
---------- ----------
Finished goods...................................... $3,597,770 $3,715,292
Work in process..................................... 50,103
Raw materials....................................... 5,505,048 2,881,870
---------- ----------
$9,102,818 $6,647,265
========== ==========
31 F-8
32
STRATASYS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
4. PROPERTY AND EQUIPMENT
Property and equipment consists of the following at December 31:
2000 1999
---------- ----------
Machinery and equipment............................. $2,496,029 $2,064,174
Computer equipment and software..................... 3,123,065 2,653,246
Office equipment.................................... 783,451 722,599
Leasehold improvements.............................. 1,257,595 1,096,479
Equipment under capital leases...................... 643,851 847,016
---------- ----------
8,303,991 7,383,514
Accumulated depreciation and amortization (including
$247,726 in 2000 and $237,676 in 1999 under
capital leases)................................... 5,398,371 4,148,152
---------- ----------
$2,905,620 $3,235,362
========== ==========
5. INTANGIBLE ASSETS
Intangible assets consist of the following at December 31:
2000 1999
---------- ----------
RPS Technology...................................... $2,558,532 $2,558,532
Capitalized software development costs.............. 3,055,663 2,652,867
Purchased software.................................. 300,000 300,000
Patents............................................. 1,311,931 1,137,687
Other............................................... 16,344 16,344
---------- ----------
7,242,470 6,665,430
Accumulated amortization............................ 3,720,909 3,255,722
---------- ----------
$3,521,561 $3,409,708
========== ==========
For the years ended December 31, 2000, 1999 and 1998, amortization of
capitalized software development costs charged to operations was $97,611,
$305,263 and $646,296, respectively.
Included in research and development expense for the years ended December
31, 2000, 1999 and 1998 are computer software development expenditures of
$1,364,175, $1,463,692 and $1,364,100, respectively.
6. PURCHASED IN-PROCESS RESEARCH AND DEVELOPMENT
In December 1998, the Company purchased substantially all of the assets of
a private research and development company, including mechanical drawings, data
tapes, code, schematics and fixed assets. The purchase price was approximately
$6,550,000, of which approximately $6,464,000 was paid in cash in January 1999
and the balance through the issuance of warrants to purchase 128,000 shares of
common stock of the Company at $13.88 per share.
The Company expects the RPS technology purchased to significantly enhance
its product mix and capabilities. Products derived from this new technology
began to reach the marketplace during 2000. At the time of purchase, substantial
development remained in order to create a functional and reliable machine. There
were also many risks involving the various areas of the technology, as well as
the total integration of the various systems. Accordingly, approximately
$6,512,000 of the purchase price was expensed as research and development
expense for the year ended December 31, 1998.
32 F-9
33
STRATASYS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
7. CREDIT LINE
The Company has an available line of credit from a financial institution
for the lesser of $2,000,000 or a defined borrowing base. The credit line bears
interest at defined rates based upon two different indexes and expires in June
2001. No amounts were outstanding at December 31, 2000 and 1999.
8. ACCOUNTS PAYABLE AND OTHER CURRENT LIABILITIES
Accounts payable and other current liabilities consist of the following at
December 31:
2000 1999
---------- ----------
Trade............................................... $1,456,502 $1,465,514
Compensation and related benefits................... 1,621,025 1,902,664
Reserve for warranty expenses....................... 160,000 157,129
Other............................................... 481,782 330,140
---------- ----------
$3,719,309 $3,855,447
========== ==========
9. OBLIGATIONS UNDER CAPITAL LEASES
Aggregate minimum lease payments for obligations under capital leases in
the years subsequent to December 31, 2000 are as follows:
YEAR ENDING DECEMBER 31,
2001.................................................... $218,380
2002.................................................... 139,898
--------
Total minimum lease payments.............................. 358,278
Less amount representing interest......................... 40,266
--------
Present value of minimum lease payments................... 318,012
Less current portion...................................... 187,692
--------
$130,320
========
10. INCOME TAXES
The components of the Company's deferred tax assets (liabilities) at
December 31, 2000 and 1999 are as follows:
2000 1999
---------- ----------
Net operating loss carryforwards.................... $ 221,000 $ 656,000
Depreciation........................................ 68,000 (4,000)
Amortization........................................ (41,000) 26,000
Allowance for doubtful accounts..................... 98,000 111,000
Reserve for warranty expenses....................... 59,000 58,000
Reserve for sales returns, net...................... 72,000 45,000
Unrealized gain on foreign currency................. (35,000)
Federal minimum tax credit carryforwards............ 162,000 154,000
Research and development tax credit carryforwards... 2,312,000 1,675,000
---------- ----------
$2,916,000 $2,721,000
========== ==========
33 F-10
34
STRATASYS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
At December 31, 2000, the Company had federal and state net operating loss
carryforwards of approximately $598,000, which can be utilized against future
taxable income and expire in various years through 2018 for federal and state.
At December 31, 2000, the Company had research and development tax credit
carryforwards of approximately $2,312,000, which can be utilized against future
federal income tax and expire in various years through 2020.
Income (loss) before income taxes (benefit) consists of the following:
2000 1999 1998
--------- ---------- -----------
United States................................. $ 822,354 $2,682,310 $(5,791,880)
Foreign....................................... 103,534 207,339 98,535
--------- ---------- -----------
$ 925,888 $2,889,649 $(5,693,345)
========= ========== ===========
The components of income taxes (benefit) for the years ended December 31,
2000, 1999 and 1998 are as follows:
2000 1999 1998
--------- ---------- -----------
CURRENT
Federal..................................... $ 51,831 $ 80,000 $ 27,011
State....................................... 42,765 (34,341)
Foreign..................................... 37,991 72,000 20,000
--------- ---------- -----------
132,587 152,000 12,670
--------- ---------- -----------
DEFERRED
Federal..................................... (231,000) 463,000 (2,211,000)
State....................................... 36,000 131,000 (177,000)
--------- ---------- -----------
(195,000) 594,000 (2,388,000)
--------- ---------- -----------
$ (62,413) $ 746,000 $(2,375,330)
========= ========== ===========
A reconciliation of the statutory federal income tax rate and the effective
tax rate follows:
2000 1999 1998
---- ---- ----
Federal statutory rate...................................... 34.0% 34.0% (34.0)%
Foreign sales corporation exclusion......................... (3.0)
Earnings of subsidiaries taxed at other than U.S. statutory
rate...................................................... (1.5)
State income taxes, net of federal effect................... 8.5 2.9 (1.9)
Permanent differences and other............................. 4.2 1.0 (0.3)
Utilization of research and development tax credit.......... (48.9) (12.1) (5.5)
----- ----- -----
Effective income tax rate................................... (6.7)% 25.8% (41.7)%
===== ===== =====
11. COMMITMENTS
The Company leases its facilities under leases which expire through 2003.
34 F-11
35
STRATASYS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
Aggregate future minimum annual rental payments in the years ended
subsequent to December 31, 2000 are as follows:
YEAR ENDING DECEMBER 31,
2001.................................................... $588,362
2002.................................................... 223,800
2003.................................................... 55,000
--------
$867,162
========
Rent expense for the years ended December 31, 2000, 1999 and 1998 was
approximately $666,000, $712,000 and $663,000, respectively.
12. STOCK OPTIONS AND WARRANTS
The Company has five employee stock option plans which have been approved
by the stockholders: Stratasys, Inc. Employee Incentive Stock Option Plan #1
(Plan 1), Stratasys, Inc. 1994 Incentive Stock Option Plan (Plan 2), Stratasys,
Inc. 1994 -- 2 Incentive Stock Option Plan (Plan 3), Stratasys, Inc. 1998
Incentive Stock Option Plan (Plan 4), and Stratasys, Inc. Incentive Stock Option
Plan (Plan 5). The five plans provide for the granting of options to qualified
employees of the Company, independent contractors, consultants and other persons
to purchase up to 2,050,000 shares of common stock.
All of the 92,848 options under Plan 1 have been granted and the plan
expires April 19, 2001. Under Plan 2, Plan 3, Plan 4, and Plan 5, options to
purchase 173,442 shares, 909,118 shares, 424,560 shares, 184,800, respectively,
of common stock have been granted. All options under the above plans are granted
at a price not less than the fair market value of the Company's common stock at
the dates of grant and are exercisable over five years. All grants are net of
terminations and expirations.
The following summarizes the information relating to outstanding stock
options and the activity during 2000, 1999 and 1998:
WEIGHTED
NUMBER AVERAGE
OF PER SHARE OPTION
SHARES OPTION PRICE PRICE
--------- ------------------- --------
Shares under option at January 1, 1998........... 870,901 $1.59 - $23.56 $14.09
Granted in 1998.................................. 224,500 5.00 - 11.56 6.75
Exercised in 1998................................ (20,865) 1.59 - 5.38 3.30
Forfeited in 1998................................ (76,320) 5.38 - 23.56 13.92
--------- ------------------- --------
Shares under option at December 31, 1998......... 998,216 1.59 - 23.56 12.68
Granted in 1999.................................. 503,100 4.53 - 9.13 5.03
Exercised in 1999................................ (1,437) 1.59 - 1.59 1.59
Forfeited in 1999................................ (91,340) 5.00 - 9.81 6.34
--------- ------------------- --------
Shares under option at December 31, 1999......... 1,408,539 1.59 - 23.56 7.09
Granted in 2000.................................. 104,232 2.34 - 11.31 7.23
Exercised in 2000................................ (19,048) 1.59 - 7.13 3.09
Expired in 2000.................................. (17,000) 5.38 - 5.38 5.38
Forfeited in 2000................................ (152,096) 4.44 - 23.50 18.45
--------- ------------------- --------
Shares under option at December 31, 2000......... 1,324,627 $1.59 - $23.56 $ 7.12
========= =================== ========
Options exercisable at December 31, 2000......... 807,147 $1.59 - $23.56 $ 8.06
========= =================== ========
F-12
35
36
STRATASYS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
The Company, as part of sales of common stock and other agreements, has
issued warrants to purchase the Company's common stock. The following summarizes
the information relating to outstanding warrants and the activity during 2000,
1999 and 1998:
WEIGHTED
NUMBER AVERAGE
OF PER SHARE WARRANT
SHARES WARRANT PRICE PRICE
-------- -------------------- --------
Shares under warrants at January 1, 1998......... 953,488 $ 5.80 - $21.00 $14.60
Granted in 1998.................................. 154,000 5.00 - 13.88 12.38
Repurchased in 1998.............................. (710,090) 13.50 - 14.50 14.08
Forfeited in 1998................................ (161,043) 5.80 - 21.00 15.95
-------- -------------------- --------
Shares under warrants at December 31, 1998 and
1999........................................... 236,355 5.00 - 15.44 12.48
Granted in 2000.................................. 121,000 3.60 - 7.00 5.58
Exercised in 2000................................ (13,000) 5.00 - 5.00 5.00
Expired in 2000.................................. (69,355) 14.00 - 15.44 14.10
Forfeited in 2000................................ (60,000) 7.00 - 7.00 7.00
-------- -------------------- --------
Shares under warrants and warrants exercisable at
December 31, 2000.............................. 215,000 $ 3.60 - $13.88 $10.06
======== ==================== ========
Had compensation cost for the Company's five stock option plans and stock
purchase warrants been determined based on the fair value at the grant date of
awards in 2000, 1999 and 1998, consistent with the provisions of SFAS 123, the
Company's net income (loss) and income (loss) per share would have been reduced
(increased) to the pro forma amounts indicated below:
2000 1999 1998
-------- ---------- -----------
Net income (loss), as reported................. $988,301 $2,143,649 $(3,318,015)
Net income (loss), pro forma................... $536,501 $1,721,787 $(3,576,561)
Basic income (loss) per share -- as reported... $ 0.18 $ 0.37 $ (0.55)
Diluted income (loss) per share -- as
reported..................................... $ 0.17 $ 0.37 $ (0.55)
Basic income (loss) per share -- pro forma..... $ 0.10 $ 0.30 $ (0.59)
Diluted income (loss) per share -- pro forma... $ 0.09 $ 0.30 $ (0.59)
The Company used the Black-Scholes option pricing model to determine the
fair value of grants made in 2000, 1999 and 1998. The following assumptions were
applied in determining the pro forma compensation cost:
2000 1999 1998
------- --------- -------
Risk-free interest rate............................... 5.94 5.57 5.63
Expected option term.................................. 4 years 3-4 years 3 years
Expected price volatility............................. 62% 67% 57%
Dividend yield........................................ -- -- --
F-13
36
37
STRATASYS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
13. EXPORT SALES
Export sales were as follows for the years ended December 31:
2000 1999 1998
----------- ----------- -----------
Europe...................................... $ 6,657,860 $ 6,348,845 $ 5,866,235
Asia Pacific................................ 8,642,917 11,070,532 7,131,958
Other....................................... 3,305,884 2,333,956 1,020,244
----------- ----------- -----------
$18,606,661 $19,753,333 $14,018,437
=========== =========== ===========
14. QUARTERLY RESULTS (UNAUDITED)
FIRST SECOND THIRD FOURTH
QUARTER QUARTER QUARTER QUARTER
---------- ---------- ----------- -----------
2000
Net sales............................. $9,298,007 $9,023,247 $ 9,001,518 $ 8,287,775
Gross profit.......................... 5,905,715 5,951,616 5,421,570 4,669,563
Net income............................ 375,764 326,894 171,481 114,162
Income per common and common
equivalent share:
Basic.............................. 0.07 0.06 0.03 0.02
Dilutive........................... 0.06 0.06 0.03 0.02
1999
Net sales............................. $7,603,144 $8,864,395 $10,359,357 $10,760,042
Gross profit.......................... 5,193,050 5,631,785 7,048,107 6,802,096
Net income (loss)..................... (193,013) 212,928 964,587 1,159,147
Income (loss) per common and common
equivalent share:
Basic.............................. (0.03) 0.04 0.17 0.20
Dilutive........................... (0.03) 0.04 0.17 0.20
F-14
37
38
STRATASYS, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED)
STRATASYS, INC. AND SUBSIDIARIES
SCHEDULE II
VALUATION AND QUALIFYING ACCOUNTS
COLUMN A COLUMN B COLUMN C COLUMN D COLUMN E
BALANCE AT ADDITIONS- DEDUCTIONS BALANCE
BEGINNING CHARGED FROM AT END
DESCRIPTION OF PERIOD TO INCOME RESERVES OF PERIOD
----------- ---------- ---------- ---------- ---------
2000
Reserve for bad debts and allowances....... $300,000 $ 1,489 $ 37,229 $264,260
======== ========== ========== ========
Reserve for sales returns and other
allowances.............................. $120,833 $1,766,397 $1,693,131 $194,099
======== ========== ========== ========
1999
Reserve for bad debts and allowances....... $279,508 $ 29,920 $ 9,428 $300,000
======== ========== ========== ========
Reserve for sales returns and other
allowances.............................. $129,833 $ 100,000 $ 109,000 $120,833
======== ========== ========== ========
1998
Reserve for bad debts and allowances....... $462,461 $ 30,000 $ 212,953 $279,508
======== ========== ========== ========
Reserve for sales returns and other
allowances.............................. $ 52,000 $ 583,080 $ 505,247 $129,833
======== ========== ========== ========
F-15
38
39
SIGNATURES
In accordance with Section 13 or 15(d) of the Securities Exchange Act of
1934, the Registrant caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
STRATASYS, INC.
By: /s/ S. SCOTT CRUMP
------------------------------------
S. Scott Crump
President
Dated: March 28, 2001
In accordance with the Securities Exchange Act of 1934, this report has
been signed below by the following persons on behalf of the Registrant and in
the capacities and on the dates indicated.
/s/ S. SCOTT CRUMP Chairman of the Board of March 28, 2001
--------------------------------------------------- Directors, President, Chief
S. Scott Crump Executive Officer, Treasurer,
(Principal Executive Officer)
/s/ THOMAS W. STENOIEN Chief Financial Officer March 28, 2001
--------------------------------------------------- (Principal Financial and
Thomas W. Stenoien Accounting Officer)
/s/ RALPH E. CRUMP Director March 28, 2001
---------------------------------------------------
Ralph E. Crump
/s/ CLIFFORD H. SCHWIETER Director March 28, 2001
---------------------------------------------------
Clifford H. Schwieter
/s/ ARNOLD J. WASSERMAN Director March 28, 2001
---------------------------------------------------
Arnold J. Wasserman
/s/ GREGORY L. WILSON Director March 28, 2001
---------------------------------------------------
Gregory L. Wilson
/s/ CAMERON TRUESDELL Director March 28, 2001
---------------------------------------------------
Cameron Truesdell